Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098670
Status:
COMPLETED
Last Update Posted:
2014-05-21
First Post:
2004-12-07
Brief Title:
Fludarabine Rituximab and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Sponsor:
Organization:
National Cancer Institute NCI